Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone Microparticles

Introduction. Ivermectin is an antiparasitic drug that has been widely used in veterinary medicine. Parasitic diseases of farm animals cause great economic damage and pose the risk of human infection. Prolonged dosage forms of ivermectin are effective against them. The first step in the creation of...

Full description

Saved in:
Bibliographic Details
Main Authors: O. I. Rybchenko, V. V. Suslov, S. A. Kedik, Yu. M. Domnina, A. I. Mogaibo
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2022-05-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/1220
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395270388809728
author O. I. Rybchenko
V. V. Suslov
S. A. Kedik
Yu. M. Domnina
A. I. Mogaibo
author_facet O. I. Rybchenko
V. V. Suslov
S. A. Kedik
Yu. M. Domnina
A. I. Mogaibo
author_sort O. I. Rybchenko
collection DOAJ
description Introduction. Ivermectin is an antiparasitic drug that has been widely used in veterinary medicine. Parasitic diseases of farm animals cause great economic damage and pose the risk of human infection. Prolonged dosage forms of ivermectin are effective against them. The first step in the creation of such a drug was the preparation and study of polymeric microparticles of polycaprolactone with encapsulated ivermectin.Aim. Obtaining polymeric microparticles of polycaprolactone with encapsulated ivermectin using a continuous flow-through unit.Materials and methods. The object of the study was microparticles of polycaprolactone with encapsulated ivermectin obtained on a continuous flow-through unit. Determination of the average particle size and size distribution was carried out by the method of laser diffraction. Microscopy was used to visually assess the shape and size of the microparticles. UV – spectrophotometry was use to quantitative determination of ivermectin.Results and discussion. Polymeric microparticles of polycaprolactone with encapsulated ivermectin was obtained and had an average size of 126.63 ± 42.67 μm and contained 32,73–62,00 % of ivermectin. Suspensions prepared from the obtained microparticles were passed through a 20G injection needle without noticeable resistance, which indicates the possibility of their use as the basis of an injectable preparation.Conclusion. Obtained results confirm the possibility of using flow-through dispersion using a device developed by us for obtaining polycaprolactone microparticles with encapsulated ivermectin, which are suitable for injection. Thus, the results obtained make it possible to continue studies of microparticles and create a drug based on them.
format Article
id doaj-art-fa3ef44b7ce246b087dec8554a79db18
institution Kabale University
issn 2305-2066
2658-5049
language Russian
publishDate 2022-05-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj-art-fa3ef44b7ce246b087dec8554a79db182025-08-20T03:39:40ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492022-05-01112798610.33380/2305-2066-2022-11-2-79-86958Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone MicroparticlesO. I. Rybchenko0V. V. Suslov1S. A. Kedik2Yu. M. Domnina3A. I. Mogaibo4Federal State Budget Educational Institution of Higher Education "MIREA – Russian Technological University"Federal State Budget Educational Institution of Higher Education "MIREA – Russian Technological University"Federal State Budget Educational Institution of Higher Education "MIREA – Russian Technological University"Federal State Budget Educational Institution of Higher Education "MIREA – Russian Technological University"Federal State Budget Educational Institution of Higher Education "MIREA – Russian Technological University"; JSC Institute of Pharmaceutical TechnologiesIntroduction. Ivermectin is an antiparasitic drug that has been widely used in veterinary medicine. Parasitic diseases of farm animals cause great economic damage and pose the risk of human infection. Prolonged dosage forms of ivermectin are effective against them. The first step in the creation of such a drug was the preparation and study of polymeric microparticles of polycaprolactone with encapsulated ivermectin.Aim. Obtaining polymeric microparticles of polycaprolactone with encapsulated ivermectin using a continuous flow-through unit.Materials and methods. The object of the study was microparticles of polycaprolactone with encapsulated ivermectin obtained on a continuous flow-through unit. Determination of the average particle size and size distribution was carried out by the method of laser diffraction. Microscopy was used to visually assess the shape and size of the microparticles. UV – spectrophotometry was use to quantitative determination of ivermectin.Results and discussion. Polymeric microparticles of polycaprolactone with encapsulated ivermectin was obtained and had an average size of 126.63 ± 42.67 μm and contained 32,73–62,00 % of ivermectin. Suspensions prepared from the obtained microparticles were passed through a 20G injection needle without noticeable resistance, which indicates the possibility of their use as the basis of an injectable preparation.Conclusion. Obtained results confirm the possibility of using flow-through dispersion using a device developed by us for obtaining polycaprolactone microparticles with encapsulated ivermectin, which are suitable for injection. Thus, the results obtained make it possible to continue studies of microparticles and create a drug based on them.https://www.pharmjournal.ru/jour/article/view/1220ivermectinpolycaprolactonemicroparticlesmicrofluidic deviceprolonged-release druginjectable drug
spellingShingle O. I. Rybchenko
V. V. Suslov
S. A. Kedik
Yu. M. Domnina
A. I. Mogaibo
Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone Microparticles
Разработка и регистрация лекарственных средств
ivermectin
polycaprolactone
microparticles
microfluidic device
prolonged-release drug
injectable drug
title Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone Microparticles
title_full Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone Microparticles
title_fullStr Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone Microparticles
title_full_unstemmed Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone Microparticles
title_short Flow Dispersion for Obtaining Ivermectin Encapsulated in Polycaprolactone Microparticles
title_sort flow dispersion for obtaining ivermectin encapsulated in polycaprolactone microparticles
topic ivermectin
polycaprolactone
microparticles
microfluidic device
prolonged-release drug
injectable drug
url https://www.pharmjournal.ru/jour/article/view/1220
work_keys_str_mv AT oirybchenko flowdispersionforobtainingivermectinencapsulatedinpolycaprolactonemicroparticles
AT vvsuslov flowdispersionforobtainingivermectinencapsulatedinpolycaprolactonemicroparticles
AT sakedik flowdispersionforobtainingivermectinencapsulatedinpolycaprolactonemicroparticles
AT yumdomnina flowdispersionforobtainingivermectinencapsulatedinpolycaprolactonemicroparticles
AT aimogaibo flowdispersionforobtainingivermectinencapsulatedinpolycaprolactonemicroparticles